Felbinac
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
biphenyl-4-ylacetic acid
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status | |
| Routes of administration |
Topical |
| Identifiers | |
| CAS Number | 5728-52-9 |
| ATC code | M02AA08 (WHO) |
| PubChem | CID: 3332 |
| DrugBank | DB07477  |
| ChemSpider | 3215 |
| UNII | 94WNJ5U8L7 |
| KEGG | D01675 |
| ChEBI | CHEBI:31597 |
| ChEMBL | CHEMBL413965 |
| Chemical data | |
| Formula | C14H12O2 |
| Molecular mass | 212.244 g/mol |
|
|
|
|
| (verify) | |
Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.[1]
Footnotes
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />References
- The Merck Index, 12th Edition. 3989
- Description of Felbinac on Tiscali [1]
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
